Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.










Sub-classes under this class:

Class Number Class Name Patents
514/14 12 to 15 peptide repeating units in known peptide chain 1,156
514/13 16 to 24 peptide repeating units in known peptide chain 1,207
514/19 2 peptide repeating units in known peptide chain 1,352
514/12 25 or more peptide repeating units in known peptide chain structure 5,904
514/18 3 or 4 peptide repeating units in known peptide chain 1,666
514/17 5 or 6 peptide repeating units in known peptide chain 1,125
514/16 7 or 8 peptide repeating units in known peptide chain 1,087
514/15 9 to 11 peptide repeating units in known peptide chain 1,423
514/9 Cyclopeptides 730
514/8 Glycoprotein (carbohydrate containing) 2,102
514/6 Heavy metal containing (e.g., hemoglobin, etc.) 461
514/3 Insulin or derivative 639
514/5 Iodine containing 44
514/7 Phosphorus containing 211
514/21 Produced by or extracted from animal tissue 2,400


Patents under this class:

Patent Number Title Of Patent Date Issued
7700548 Method for reducing the likelihood of spontaneous abortion presenting a sign or symptom of threatened abortion Apr. 20, 2010
7700547 Preventing airway mucus production by administration of EGF-R antagonists Apr. 20, 2010
7700546 Therapeutic agent for cancer Apr. 20, 2010
7700545 Use of NF-.sub..kappa.B inhibition in combination therapy for cancer Apr. 20, 2010
7700544 Compositions and methods for treating atherosclerosis Apr. 20, 2010
7700543 Use NF-.sub..kappa.B inhibition in combination therapy for cancer Apr. 20, 2010
7700353 Compositions and methods for inducing apoptosis in tumor cells Apr. 20, 2010
7700322 Method for stable gene-amplification in a bacterial host cell Apr. 20, 2010
7700132 Isolated material having an anti-organotrophic effect Apr. 20, 2010
7700121 Gene associated with leishmania parasite virulence Apr. 20, 2010
7700120 Adjuvancy and immune potentiating properties of natural products of Onchocerca volvulus Apr. 20, 2010
7700113 Inhibiting breast cancer cell growth by administering an intracellular domain of NOTCH2 Apr. 20, 2010
7700087 Compounds and methods to inhibit or augment an inflammatory response Apr. 20, 2010
7700073 Use of NF-.kappa.B inhibition in combination therapy for cancer Apr. 20, 2010
7696176 Blood replacement product Apr. 13, 2010
7696171 Mutant polypeptides of fibroblast growth factor 1 Apr. 13, 2010
7696169 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents Apr. 13, 2010
7696160 Compositions useful for and methods of modulating angiogenesis Apr. 13, 2010
7696159 Treatment for basal cell carcinoma Apr. 13, 2010
7696158 Use of IL-22 for the treatment of conditions of metabolic disorders Apr. 13, 2010
7696157 Methods and means for producing proteins with predetermined post-translational modifications Apr. 13, 2010
7696156 Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof Apr. 13, 2010
7696155 Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof Apr. 13, 2010
7696154 Methods for treating interleukin-18 mediated disorders with interleukin-18 binding proteins Apr. 13, 2010
7696153 G-CSF conjugates Apr. 13, 2010
7696152 Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL) Apr. 13, 2010
7696151 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents Apr. 13, 2010
7696150 Modulation of the activity of an interleukin 17 receptor-related protein, EVI27, and uses thereof Apr. 13, 2010
7696149 Pharmaceutical administration form for peptides, process for its preparation, and use Apr. 13, 2010
7696148 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense Apr. 13, 2010
7695732 Nutritional composition for the treatment of pressure ulcers Apr. 13, 2010
7695729 Nonoral preparation having three-layer structure Apr. 13, 2010
7695723 Methods of treating neurological conditions with hematopoietic growth factors Apr. 13, 2010
7695722 Methods for reducing GNRH-positive tumor cell replication Apr. 13, 2010
7695719 Conjugates of therapeutic or cytotoxic agents and biologically active peptides Apr. 13, 2010
7691906 High lipid diet Apr. 6, 2010
7691829 Composition and method for healing tissues Apr. 6, 2010
7691816 Pharmaceutical compositions Apr. 6, 2010
7691814 Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2 Apr. 6, 2010
7691809 Lactoferrin for age related disorders in humans Apr. 6, 2010
7691808 Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction Apr. 6, 2010
7691807 Hybrid oligomers, their preparation process and pharmaceutical compositions containing them Apr. 6, 2010
7691806 Repeat sequence protein polymer active agent congjugates, methods and uses Apr. 6, 2010
7691805 Antimicrobial compounds Apr. 6, 2010
7691804 BAFF receptor (BCMA), an immunoregulatory agent Apr. 6, 2010
7691603 Intracellular formation of peptide conjugates Apr. 6, 2010
7691396 Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes Apr. 6, 2010
7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds Apr. 6, 2010
7691381 Stabilized biodegradable neurotoxin implants Apr. 6, 2010
7691366 Chimeric CMP-Ang1 molecule Apr. 6, 2010











 
 
  Recently Added Patents
Automated hotfix handling model
Dry-cooling unit with gravity-assisted coolant flow
Methods and systems for assessing sales activity of a merchant
Methods, devices and computer program products providing for establishing a model for emulating a physical quantity which depends on at least one input parameter, and use thereof
Manufacturing process for cellular screening substratum, resultant substratum, and method and apparatus for screening
Electronic device with a screen
Glycosyltransferase promoter
  Randomly Featured Patents
Piezoelectric ceramic and piezoelectric ceramic element including the same
Process for the manufacture of persalt particles
Ring-based public key cryptosystem method
Fold-away chair
Energy dependent quantization for efficient coding of spatial audio parameters
Process for producing a natural gas substitute
System and method for multi-modal control of an autonomous vehicle
Locator plug system
Window shade mechanism for a modular aircraft window
Optical apparatus, photomask inspecting apparatus, and exposure apparatus